DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Xarelto (Rivaroxaban) - Current Clinical Trials

 
 



Xarelto Related Clinical Trials

Rivaroxaban for Treatment of Patients With Suspected or Confirmed Heparin-Induced Thrombocytopenia [Recruiting]

A Pharmacokinetics, Pharmacodynamics and Safety Study of Single Dose of Rivaroxaban in Participants With End-Stage Renal Disease (ESRD) on Maintenance Hemodialysis [Completed]

Xarelto [SPAF] Post-marketing Surveillance in Japan [Recruiting]

Switching Study From Warfarin to Rivaroxaban [Completed]

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Sweden) [Recruiting]

Dose-finding of Rivaroxaban in Hemodialysis [Completed]

Xarelto [SPAF-QOL] Post-marketing Surveillance in Japan [Recruiting]

Treatment of Rivaroxaban Versus Aspirin for Non-disabling Cerebrovascular Events [Not yet recruiting]

A Study to Assess the Effects of 2 Different Prothrombin Complex Concentrates on the Pharmacodynamics of Rivaroxaban in Healthy Adult Volunteers [Completed]

XENITH: Rivaroxaban for Pulmonary Embolism Managed With Catheter Directed Thrombolysis [Not yet recruiting]

Rivaroxaban for Scheduled Work-up of DVT - The Ri-Schedule Study [Recruiting]

Rivaroxaban Compared to Vitamin K Antagonist Upon Development of Cardiovascular Calcification [Recruiting]

Anticoagulation With Rivaroxaban in Cardioversion -The ARC Study [Completed]

Rivaroxaban in Thrombotic Antiphospholipid Syndrome [Recruiting]

Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer [Recruiting]

The Effect of Rivaroxaban in Sickle Cell Disease [Enrolling by invitation]

Rivaroxaban in Bariatric Surgery [Enrolling by invitation]

Rivaroxaban Versus Warfarin in Acute Ischemic Stroke With Atrial Fibrillation [Recruiting]

Efficacy and Safety of Rivaroxaban for the Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation [Completed]

Rivaroxaban for Antiphospholipid Antibody Syndrome [Recruiting]

The Blood Saving Effect of Tranexamic Acid in Total Knee Arthroplasty With Rivaroxaban as Thromboprophylaxis [Completed]

Study to Observe Safety of Xarelto in VTE Prophlylaxis After Elective TKR (Total Knee Replacement) or THR (Total Hip Replacement) [Suspended]

Rivaroxaban Effects in Subjects Who Have Undergone Gastric Bypass Surgery [Recruiting]

Anti-inflammatory Effects of Rivaroxaban Versus Dabigatran [Recruiting]

A Study of Erythromycin and Rivaroxaban in Study Participants With Normal and Reduced Kidney Function [Completed]

Relative Bioavailability Study in Healthy Subjects Comparing 2 Dry Powder Oral Suspensions of Rivaroxaban Under Fasting and 20 mg of an Oral Suspension of Rivaroxaban Under Fed Conditions to 10 mg of an Immediate Release Tablet Under Fasting Conditions [Completed]

Bioequivalence Study in Healthy Subjects, 2*5 mg Tablets Rivaroxaban Versus 1*10 mg Tablet Rivaroxaban [Completed]

Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center [Not yet recruiting]

BAY59-7939 in Atrial Fibrillation Once Daily (OD) [Completed]

BAY59-7939 Japanese in Atrial Fibrillation (2nd) [Completed]

Relative Bioavailability of Oral Suspension of Rivaroxaban Compared to Standard Tablet [Completed]

RIvaroxaban for Valvular Heart diseasE and atRial Fibrillation Trial -RIVER Trial [Not yet recruiting]

Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thromboembolism (DVT) and Pulmonary Embolism (PE). A Study of BAY59-7939 in the Prevention of Venous Thrombo Embolism (VTE) in Subjects Undergoing Elective Total Knee Replacement. [Completed]

Explore the Efficacy and Safety of Once-daily Oral Rivaroxaban for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for Cardioversion [Completed]

Efficacy of RIvaroxaban for Prevention of Venous Thromboembolism After Knee Arthroscopy [Recruiting]

Exploring the Efficacy and Safety of Rivaroxaban to Support Elective Percutaneous Coronary Intervention [Completed]

A Study to Explore the Pharmacodynamic Changes When Transitioning From Rivaroxaban to Warfarin in Healthy Volunteers [Completed]

Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer [Completed]

A Prospective Pharmacodynamic Study of Rivaroxaban [Completed]

Study in Cancer Patients With Central Line Associated Clots in the Upper Extremity Treated With Rivaroxaban (Catheter 2) [Recruiting]

Satisfaction/Quality of Life With Rivaroxaban in DVT (Deep Venous Thrombosis) Indication [Active, not recruiting]

Satisfaction/Quality of Life With Rivaroxaban in SPAF (Stroke Prevention in Atrial Fibrillation) Indication [Completed]

Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux [Recruiting]

EINSTEIN Junior Phase III: Oral Rivaroxaban in Children With Venous Thrombosis [Recruiting]

Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care Therapy [Recruiting]

Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation [Completed]

Switching Drug Therapy for the Prevention of Blood Clot Formation From Enoxaparin to Rivaroxaban After Orthopedic Surgery for Either Total Hip or Total Knee Replacement [Completed]

Validation of Rivaroxaban Assay for US Registration [Recruiting]

Study in Healthy Volunteers of the Reversion by Haemostatic Drugs of the Anticoagulant Effect of New Anti-thrombotics [Completed]

Pilot Study to Examine the Use of Rivaroxaban After Angioplasty for Critical Limb Ischemia [Recruiting]

EINSTEIN Junior Phase II: Oral Rivaroxaban in Young Children With Venous Thrombosis [Recruiting]

Rivaroxaban in Combination With Aspirin Alone or With Aspirin and a Thienopyridine in Patients With Acute Coronary Syndromes (The ATLAS ACS TIMI 46 Trial) [Completed]

Observational Study to Assess Sociodemographic and Clinical Features of Patients Treated With Rivaroxaban in Routine Clinical Practice of Hematologists, Cardiologists and Internists of Spain [Completed]

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Germany) [Recruiting]

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK) [Recruiting]

Exploring the Efficacy of Once Daily Oral Rivaroxaban for Treatment of Thrombus in Left Atrial/Left Atrial Appendage in Subjects With Nonvalvular Atrial Fibrillation or Atrial Flutter [Completed]

Belgian Real Life Non-interventional Study (NIS) in Patients Treated With Xarelto Following an Acute Deep Vein Thrombosis (DVT) [Completed]

Phase I Study on Rivaroxaban Dry Powder Suspension in Children [Not yet recruiting]

Belgian Real Life Non-interventional Study (NIS) on Xarelto in Non-valvular Atrial Fibrillation (AF) Patients Treated for the Prevention of Stroke and Systemic Embolism [Completed]

Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation in Latinamerica and EMEA Region [Recruiting]

Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation in Asia [Recruiting]

Dose-ranging Study of Once-daily Regimen of BAY 59-7939 in the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement [Completed]

Xarelto Regulatory Post-Marketing Surveillance [Completed]

Once-daily Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Deep-vein Thrombosis [Completed]

Pharmacokinetics Study of Oral Rivaroxaban in Healthy Participants [Completed]

Oral Rivaroxaban in Children With Venous Thrombosis [Recruiting]

Evaluation of Wound Drainage After Knee or Hip Arthroplasty [Recruiting]

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands) [Recruiting]

Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy [Completed]

BAY 59-7939 (Xarelto, SPAF), Non Interventional Studies [Completed]

Xarelto for VTE Prophylaxis After Hip or Knee Arthroplasty [Completed]

Comparison of Topical and Infusion Tranexamic Acid After Total Knee Arthroplasty [Not yet recruiting]

A Study in Older Subject to Evaluate the Safety and Ability of Andexanet Alfa to Reverse the Anticoagulation Effect of Rivaroxaban [Recruiting]

Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in Atrial Fibrillation [Recruiting]

Comparative Study of Prophylactic Agent for Venous Thromboembolism After Total Knee Arthroplasty [Recruiting]

Rivaroxaban Versus Warfarin in the Evaluation of Progression of Coronary Calcium [Recruiting]

Comparison of Antithrombotic Treatments After Aortic Valve Replacement. Rivaroxaban: A New Antithrombotic Treatment for Patients With Mechanical Prosthetic Aortic Heart Valve. [Recruiting]

Patient and Physician Knowledge of Key Safety Messages [Recruiting]

Dose-Ranging Study of BAY 59-7939 on the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement [Completed]

A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy [Completed]

Rivaroxaban in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention [Recruiting]

Pharmacogenomic Study on PKD/PKC of Dabigatran Etexilate and Rivaroxaban [Completed]

Rivaroxaban Anticoagulation for Superficial Vein Thrombosis [Recruiting]

Comparison of Blood Loss Following Total Hip Arthroplasty With the Use of Three Thromboprophylactic Regimes: Dabigatran, Enoxaparin and Rivaroxaban. [Recruiting]

Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban to Aspirin Following Total Hip and Knee Arthroplasty [Recruiting]

Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017